Jack Andraka – The Teen Prodigy of Pancreatic Cancer Research


Jack Andraka – The Teen Prodigy of Pancreatic Cancer Research

Jack Andraka was born in the United States in 1997. At the age of 15, he developed a test to detect early-stage pancreatic cancer. Andraka hoped that his invention could provide an affordable alternative to the standard diagnostic test which costs approximately $800. This high price makes testing unaffordable for many people in the US, and even when people do get tested, over 30% of the tests generate false results.

However, Andraka postulated that a protein called mesothelin is unique to the bodies of pancreatic cancer patients. He invented a testing method for mesothelin that involves only a small piece of filter paper and which costs three cents, takes five minutes, and is purportedly 400 times more accurate than conventional testing methods. However, his findings were deemed inadequate because there were still many factors that needed to be examined more precisely.

Wanting to further develop his research, Jack emailed his findings to 200 pancreatic cancer specialists in the U.S., but most of them did not respond. One day, however, he received a reply from a specialist working at John Hopkins University, stating that he would like to support his research. After collaborating with this specialist, it turned out that there were problems with the test method that Jack had devised that affected its validity.

Although there is still much progress to be made in the way of accurately testing for pancreatic cancer, Andraka became known to medical professionals throughout the US for his innovation and determination. He has also received interest from drug companies, has received awards, and given multiple TED Talks. Although the testing method he invented has not been authorised for general use, it is hoped that his medical research will prove valuable to oncology in the long-run.


・pancreatic cancer・・すい臓がん

ジャック・アンドレイカ – 膵臓がん研究の天才少年




膵臓がんの正確な検査にはまだ多くの課題がありますが、アンドレイカはその革新性と決断力で全米の医療関係者に知られるようになりました。また、製薬会社からも関心を寄せられ、賞も受賞し、TED Talksにも何度も登場しています。彼が発明した検査方法は、まだ一般的な使用が許可されていませんが、彼の医学研究が長期的には腫瘍学にとって貴重なものとなることが期待されています。


Follow me!